Regarding the symptoms of VIIP and AMS, the oxygen-regulated gene vascular endothelial growth factor (VEGF) is of central interest as being up-regulated by rather mild tissue hypoxia17. This evidence concerns the gene VEGFA and ablepharon macrostomia syndrome.